One of the diagnostic criteria of essential thrombocythemia laboratory characteristics, except for a significant increased patients' age and decreased polymorphonuclear cell count (ET) is the absence of the Philadelphia chromosome (Phneg). On the molecular level, Ph-neg ET patients may carry in the BCR-ABL positive group. During a median follow-up of 20 and 22.5 months for the BCR-ABL negative and positive BCR-ABL transcript. The natural history of BCR-ABL positive Ph-neg ET patients is undetermined. We examined the BCRgroups, respectively, there was neither blastic transformation nor unrelated death in both groups. We conclude that ABL status by reverse transcriptase two-step nested polymerase chain reaction in bone marrow aspirates of 25 it is important to look for BCR-ABL transcript in Ph-neg ET patients and to follow them closely to investigate the nature Ph-neg ET patients. We found 12 BCR-ABL positive and 13 BCR-ABL negative patients in the study group. We have initiated a study aimed at further characterization
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MATERIALS AND METHODS

E
ability. 5, 6 It has been suggested that the abnormal hybrid We have initiated a study aimed at further characterization
Reverse transcriptase two-step nested polymerase chain reaction of Ph-neg ET patients. We analyzed the molecular profile the starting template for the outer primer polymerase reaction. Each patient's sample was transcribed in two tubes. PCR was performed by using the same sets of primer sequences as described by Hughes et al. 13 cDNA was amplified by 2.5 U of Taq Polymerase (Appligene,
From the Division of Hematology and Epidemiology Unit, Rabin
Strasbourg, France). In one tube, the reaction was performed in the Medical Center, Beilinson Campus, Petah-Tikva, Israel. presence of outer primers (A and B), which amplify cDNA derived Submitted February 3, 1997; accepted June 5, 1997. from b3a2 and b2a2 transcripts of BCR-ABL mRNA. Nylon membrane (GeneScreen Plus, Dupont, NEN Research Prodrepeated independently two to three times. Negative results were regarded as true only when a successful ABL PCR product was ucts, Boston, MA) using an alkaline transfer protocol by the method of Southern.
14 Membranes were hybridized with 5-end fluorsceindemonstrated. Cytogenetic analysis. Mononuclear marrow cells were separated labeled DNA probes for b3a2 and b2a2, as described by Kawasaki et al. 15 A chemiluminescent detection kit (Tropix Inc, Bedford, MA) as described above and cultured at a concentration of 1 1 10 6 /mL in RPMI 1640 medium with 20% fetal calf serum, 10 g/mL Lwas used for detection.
Detection limit controls. The detection limit of the method was glutamine, 10 g/mL penicillin and streptomycin. Cultures were incubated for 24 to 72 hours at 37ЊC. Cells were harvested according to established by adding 100 K562 cells expressing BCR-ABL transcript (b3a2) to 10 7 nonexpressing HL-60 cells. Total RNA was a standard protocol. Metaphase preparations were G-banded using the method of Seabright 17 and analyzed according to the international extracted and was used as a positive control in all experiments. As a negative control, we used RNA extracted from HL-60 cells or system for human cytogenetic nomenclature (ISCN) guidelines. 18 A total of 20 to 30 metaphases were analyzed. healthy normal volunteers, and a blank control was added to eliminate the possibility of reagent contamination. The recommendations Statistical analysis. We used the two-sided Student's t-test to compare the means of continuous variables examined in our study. of Kwok and Higushi 16 were followed. Each positive result was P values less than .05 were considered statistically significant.
RESULTS
Table 1. Clinical Data at Diagnosis of the Two Groups of Ph-neg ET Patients
Twenty-seven patients were enrolled in the study, two of whom were excluded because of failed bone marrow aspira- and group B consisted of 12 (48%) patients who were BCRSymptoms ABL positive (Fig 1) . In group B, a junction between the exon (b2) of M-bcr and a2 in four cases (33.3%) (Fig 1) .
Spleen
Some of the patients (PCR positive and negative) were tested Unpalpable 8 10 repeatedly after 6 to 12 months from the first PCR. Specific-
ity of the PCR products was confirmed by Southern blot õ3 cm 2 1 using b3a2 and b2a2 specific DNA probes.
¢3 cm 3 1 the laboratory data of the two groups of patients at diagnosis.
no increase in spleen size, whereas splenomegaly is present in about 90% of CML patients at diagnosis 22 ; (4) there was The comparison of the tested variables shows that the two groups had similar clinical characteristics, as well as laborano blastic transformation or unrelated death in the BCR-ABL positive group during a median follow-up of 22.5 tory results except for a significant increase in the polymorphonuclear (PMN) cell counts accompanied by a decrease months, which contrasts the onset of blastic crisis in CML patients.
23
in lymphocytes and monocytes in group A. It should be noted that the LAP score of all patients was within the norIt was recently reported that 22 of 73 (30.1%) healthy adults carry the BCR-ABL transcript in their peripheral mal range.
During a median follow-up of 20 and 22.5 months for blood, 24 which is quite close to the rates (48%) of BCR-ABL transcripts in the bone marrow aspirates of our ET groups A and B, respectively, there were neither blastic transformations nor unrelated deaths in the respective two study group. It could be that by adopting the method used by Biernaux et al, 24 which is much more sensitive (1:10 8 groups of patients. cells) than the one used in our laboratory (1:10 5 ), in patients DISCUSSION with a myeloproliferative disorder, a higher rate of BCR-ABL positive transcripts may be discovered. This would Stoll et al 10 observed that less than 10% of patients with suggest that the incidence of BCR-ABL transcript found in the clinical features of ET may have the Philadelphia chroour study is not a reflection of the incidence found in the mosome in their myeloid cells, which is associated with a general population. poor prognosis.
11 Some of the patients, described in small Using the fluorescence in situ hybridization (FISH) techseries during the last few years, had several combinations of nique in adjunct to the cytogenetic analysis may detect com-CML features including leukocytosis, basophilia, low LAP plex and subtle rearrangements of Ph translocation score, or immature myeloid cells in peripheral blood. [9] [10] [11] (''masked'' Ph-chromosome) in 3.4% to 15% of CML The molecular analysis of the bone marrow aspirates of cases. 25 Because our group was small, the FISH technique our ET patients showed that about half of these patients would have omitted from the data a negligible part of the carried the BCR-ABL transcripts in their mononuclear cells.
patients, which would not change the concept presented We did not identify which cell lineage expresses BCR-ABL herein. transcripts, but in CML, it is conceived that the translocation It is assumed that random chromosomal aberrations inoriginates in a pluripotent stem cell involving both myeloid crease with age. However, in our study, the significantly and lymphoid linages.
19 Our BCR-ABL positive group was older age of patients in the BCR-ABL positive group was clinically indistinguishable from the group of BCR-ABL associated with an otherwise normal karyotype except the negative ET patients.
BCR-ABL fusion gene, which was the only translocation The results raise the possibility that BCR-ABL positive searched for. Thus, the question whether the frequency of ET patients are, in fact, CML patients. We assume that this BCR-ABL positive status in ET patients is age-dependent is not the case because (1) the BCR-ABL positive group had remains to be further investigated. normal LAP scores on admission without any evidence of
We believe that a longer study follow-up period is needed inflammation, infection or therapy, while 91% of CML pato observe the sequence of events leading to the appearance tients had low or abscent LAP score 20 ; (2) there was no of BCR-ABL transcripts and its contribution to the patients' associated basophilia, in contrast to CML patients in whom basophilia is virtually always present 21 ; (3) the majority had prognosis.
AID Blood 0018 / 5h3e$$$341 08- on treatment modalities in ET, and the role of interferon Biotechniques 15:532, 1993 treatment in this group should be assessed. In addition, the 13. Hughes TP, Morgan GJ, Martiat P, Goldman JM: Detection of results may raise the possibility of defining a new variant of residual leukemia after bone marrow transplant for chronic myeloid ET whose significance is yet to be explored. leukemia: Role of polymerase chain reaction in predicting relapse.
In conclusion, we suggest that the BCR-ABL status be Blood 77:874, 1991 examined in ET patients and that they be followed closely to 14. Southern EM: Detection of specific sequences among DNA understand the nature of our observation and its importance. fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975 15. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R,
